Who are some of the prominent players in the paracetamol IV industry?

Key players in the industry include AdvaCare Pharma, Altan Pharma, B. Braun SE, Cipla Inc., Criticine Care, Fresenius Kabi, GNova Biotech, Lupin, Mallinckrodt Pharmaceuticals, and Pfizer.

How much is the U.S. paracetamol IV industry worth?

The U.S. paracetamol IV market was valued at USD 340.4 million in 2024, driven by the rising demand for effective pain management solutions and strong regulatory support.

Why is the surgical segment dominant in the paracetamol IV industry?

The surgical segment was valued at USD 642.3 million in 2024, primarily due to its widespread use in postoperative pain management and fever reduction, reducing the need for opioid analgesics.

How big is the paracetamol IV market?

The global paracetamol IV industry was valued at USD 860.7 million in 2024 and is estimated to grow at a 4.2% CAGR from 2025 to 2034, driven by its effective analgesic and antipyretic properties.

Paracetamol IV Market Share

Report ID: GMI12321

Published Date: November 2024

Report Format: PDF

Download Free PDF

Paracetamol IV Market Share

The market is composed of major global pharmaceutical firms and domestic ones. Established pharmaceutical markets have IV forms of paracetamol infused with other medications that are marketed under numerous brand names. Furthermore, several generic drug producers enhance market competition through their cheap versions. Market players are focusing on product differentiation, obtaining regulatory approvals, and engaging in mergers and alliances to strengthen their core competencies in the competitive markets.

Paracetamol IV Market Companies

Few of the prominent players operating in the paracetamol IV industry include:

AdvaCare Pharma
Altan Pharma
B. Braun SE
Cipla Inc.
Criticine Care
Fresenius Kabi
GNova Biotech
Lupin
Mallinckrodt Pharmaceuticals
Pfizer
Solitaire Pharmacia
Unital Pharmaceuticals

Authors: Mariam Faizullabhoy, Gauri Wani

Frequently Asked Question(FAQ) :

Who are some of the prominent players in the paracetamol IV industry?: Key players in the industry include AdvaCare Pharma, Altan Pharma, B. Braun SE, Cipla Inc., Criticine Care, Fresenius Kabi, GNova Biotech, Lupin, Mallinckrodt Pharmaceuticals, and Pfizer.
How much is the U.S. paracetamol IV industry worth?: The U.S. paracetamol IV market was valued at USD 340.4 million in 2024, driven by the rising demand for effective pain management solutions and strong regulatory support.
Why is the surgical segment dominant in the paracetamol IV industry?: The surgical segment was valued at USD 642.3 million in 2024, primarily due to its widespread use in postoperative pain management and fever reduction, reducing the need for opioid analgesics.
How big is the paracetamol IV market?: The global paracetamol IV industry was valued at USD 860.7 million in 2024 and is estimated to grow at a 4.2% CAGR from 2025 to 2034, driven by its effective analgesic and antipyretic properties.

Related Reports

Authors: Mariam Faizullabhoy, Gauri Wani

Buy Now

Single User: $4,123 $4,850

15% off

Multi User: $4,840 $6,050

20% off

Enterprise User: $5,845 $8,350

30% off

Buy now

Premium Report Details

Base Year: 2024

Companies covered: 12

Tables & Figures: 108

Countries covered: 19

Pages: 140

Download Free PDF

Paracetamol IV Market Share

Paracetamol IV Market Share

Paracetamol IV Market Companies

Premium Report Details

Industries

Information

Link

Global Headquarters